Rafferty Asset Management’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$665K Sell
71,396
-12,017
-14% -$105K ﹤0.01% 854
2025
Q4
$626K Buy
+83,413
New +$846K ﹤0.01% 878
2024
Q4
Sell
-90,348
Closed -$977K 1154
2024
Q3
$977K Sell
90,348
-5,217
-5% -$86.6K ﹤0.01% 806
2024
Q2
$2.01M Sell
95,565
-96,816
-50% -$2.43M 0.01% 637
2024
Q1
$6.13M Buy
192,381
+65,792
+52% +$1.68M 0.02% 424
2023
Q4
$2.56M Sell
126,589
-34,697
-22% -$457K 0.01% 613
2023
Q3
$2.05M Sell
161,286
-35,869
-18% -$600K 0.01% 605
2023
Q2
$3.56M Buy
197,155
+62,367
+46% +$1.15M 0.02% 488
2023
Q1
$2.32M Buy
134,788
+86,855
+181% +$1.69M 0.02% 564
2022
Q4
$1.06M Buy
+47,933
New +$740K 0.01% 740
2022
Q2
Sell
-71,774
Closed -$1.08M 1162
2022
Q1
$1.08M Sell
71,774
-3,939
-5% -$61.9K 0.01% 762
2021
Q4
$1.66M Buy
+75,713
New +$1.86M 0.01% 722

Other funds holding FDMT